Effects Of App-Supported Transitional Care On Neurogenic Bladder In Spinal Cord Injury Patients
10. juni 2026 opdateret af: Tian Zhang, Xiamen University
Effects Of App-Supported Transitional Care On Bladder Function And Quality Of Life in Patients With Neurogenic Bladder After Incomplete Spinal Cord Injury: A Randomised Controlled Trial
This is a single-blind randomized controlled trial for patients with neurogenic bladder after incomplete spinal cord injury.
Participants are randomly divided into two groups.
The control group receives routine transitional nursing and telephone follow-up, while the intervention group gets 4-week app-supported transitional care including health education, bladder recording and online consultation.
After intervention, bladder residual urine, urinary tract infection rate, self-care ability and quality of life are compared between two groups.
Studieoversigt
Status
Afsluttet
Detaljeret beskrivelse
Neurogenic bladder is a common complication after incomplete spinal cord injury, which easily leads to recurrent urinary tract infection and decreased quality of daily life.
Traditional transitional follow-up is limited by time and space.
This study adopts single-blind parallel-group RCT design.
Eligible patients are randomly allocated at a 1:1 ratio.
Control group receives standard inpatient nursing plus conventional post-discharge follow-up; intervention group receives identical inpatient care plus systematic app-based transitional care for 4 weeks.
Primary outcomes are post-void residual urine volume and urinary tract infection incidence.
Secondary outcomes contain self-care ability and quality of life assessed by standardized scales.
All indicators are tested at baseline and 4 weeks after intervention to verify the clinical effect of app-assisted transitional nursing.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
88
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Jilin
-
Siping, Jilin, Kina, 136000
- Siping Central People's Hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
Diagnosed with neurogenic bladder secondary to incomplete spinal cord injury; Age ranging from 18 to 75 years old; Clear consciousness, capable of cooperating with nursing assessment and mobile APP follow-up management; Voluntarily sign written informed consent. -
Exclusion Criteria:
Combined with severe renal insufficiency, malignant tumor or other life-threatening severe systemic diseases; History of previous bladder reconstructive surgery; Cognitive impairment unable to independently operate mobile APP; Refuse to continue follow-up or withdraw voluntarily during the research period.
-
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Control Group
Patients receive routine standardized inpatient bladder nursing, only one-time routine telephone follow-up after discharge without APP-based transitional care intervention
|
routine standardized inpatient bladder nursing
|
|
Eksperimentel: Intervention Group
Same routine inpatient nursing as control group plus 4 weeks of systematic APP-supported transitional care including health education, voiding record management and online nurse consultation.
|
routine standardized inpatient bladder nursing
Four-week continuous transitional nursing service via mobile APP for patients with neurogenic bladder after incomplete spinal cord injury, including disease-related health education, real-time voiding record, regular nursing reminder and online one-on-one nurse consultation, which differs from routine single telephone follow-up in control group.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of urinary tract infection
Tidsramme: Within 4 weeks after subject enrollment
|
Count the occurrence of urinary tract infection within 4-week follow-up and calculate infection incidence of each group.
|
Within 4 weeks after subject enrollment
|
|
Post-void residual urine volume
Tidsramme: Baseline and 4 weeks after intervention
|
Bladder residual urine volume is measured by ultrasonic examination at baseline and after 4 weeks of nursing intervention to compare the difference between two groups.
|
Baseline and 4 weeks after intervention
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-care ability and quality of life score
Tidsramme: Baseline and 4 weeks after intervention
|
Standardized scale scoring for self-care and quality of life before and after 4-week transitional nursing.
|
Baseline and 4 weeks after intervention
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
10. januar 2026
Primær færdiggørelse (Faktiske)
1. maj 2026
Studieafslutning (Faktiske)
1. maj 2026
Datoer for studieregistrering
Først indsendt
6. juni 2026
Først indsendt, der opfyldte QC-kriterier
10. juni 2026
Først opslået (Faktiske)
11. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
11. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
10. juni 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Urogenitale sygdomme
- Neurologiske manifestationer
- Sygdomme i centralnervesystemet
- Sygdomme i nervesystemet
- Sår og skader
- Mandlige urogenitale sygdomme
- Urologiske sygdomme
- Urogenitale sygdomme hos kvinder
- Kvinders urogenitale sygdomme og graviditetskomplikationer
- Traumer, nervesystemet
- Urinblæresygdomme
- Rygmarvssygdomme
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Rygmarvsskader
- Urinblære, neurogen
Andre undersøgelses-id-numre
- SKYLW-2024-001
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
Individual participant raw data will not be shared publicly due to patient privacy protection and relevant hospital data management regulations.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .